价格

CHEMI SPA

VIA DEI LAVORATORI 54, Cinisello Balsamo, Milano, 意大利

概览

试验阶段分布

阶段

试验数

占比

1 期

50.0%

2 期

33.3%

试验状态分布

进行中（未招募）

33.3%

已完成

66.7%

药物批准

按机构分类的批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

HEPAXANE 4.000 UI (40 MG)/0,4 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 12.000 UI (120 MG)/0,8 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 10.000 UI (100 MG)/1 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 2.000 UI (20 MG)/0,2 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 8.000 UI (80 MG)/0,8 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 15.000 UI (150 MG)/1 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

HEPAXANE 6.000 UI (60 MG)/0,6 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2018-09-26

MUSTINAL 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

CIMA_AEMPS

2017-06-13

STEOZOL 4 mg/5 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EN JERINGA PRECARGADA

CIMA_AEMPS

2013-01-24

资讯

暂无资讯文章

返回机构列表

CHEMI SPA

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（6）

Study for the LF-PB (30mg) efficacy evaluation on seroma incidence and duration after axillary dissection in patient with breast cancer

Extended-release of Octreotide (LF-PB) for the Treatment of Seroma

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions

Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea

A randomized double-blind study, performed with the use of placebo, to assess the efficacy of the drug LF-PB at different doses to treat linforrea after removal of axillary lymph nodes in patients with breast cancer.

药物批准

按机构分类的批准

近期批准

资讯